Firm unveils UK partner and senior associate promotions
The patent attorneys will be based in London and Birmingham.
US firm adds partner to Minnesota office
New addition joins from Fish & Richardson where he was a principal for five years.
USITC to investigate potential section 337 breach in trade secrets case
Viking alleges Chinese competitor stole information relating to metabolic disorders drug.
Deny Amgen’s ‘dangerous’ patent claims, Sanofi urges Supreme Court
French pharma firm urges US court not to allow ‘monopoly’ over market | Enablement issue at centre of antibody patent case could have wide implications for pharma and life sciences industries.
Governments may have to reserve 20% of vaccines: WHO
Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.
Boston Scientific loses stent patent case in uni feud
Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.
Apple suffers another bruising in smartwatch tech clash
Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.
Cigna pursues trade secrets in ‘non-competes’ dispute
Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.
Blank Rome hires new patent agent for Texas office
Blank Rome has brought in patent agent Joseph Jackson to the firm’s IP and Technology practice group in Houston.
BMS sues AstraZeneca for infringing cancer treatment drug
US pharma giant says competitor’s drug Imjudo violates two patents | BMS’ blockbuster was first to use checkpoint inhibitors, says complaint.
